Celon Pharma (Poland)

Recent papers from Celon Pharma (Poland)

1. When Does Magnesium Stearate Improve Carrier-Based Dry Powder Inhalers (DPI) Performance? A Critical Review of Material, Process, and Formulation FactorsPharmaceuticals · 2026
2. Physical and mental health-related quality of life outcomes of non-pharmacological interventions in early multiple sclerosis: A systematic review and meta-analysisClinical Rehabilitation · 2026
3. PDE10A Inhibition in Schizophrenia: A Randomised, Placebo-Controlled Phase 2 Study of Alofropodect (CPL’36) in Patients Experiencing Acute SchizophreniaCNS Drugs · 2026
4. Novel EGFR tyrosine kinase inhibitors exhibiting intrinsic fluorescenceInvestigational New Drugs · 2026
5. NMR-AI: An Open Platform for NMR-Enhanced Molecular Representations and Physicochemical Property PredictionJournal of Chemical Information and Modeling · 2026
6. Abstract 3080: Site-specific conjugation of CPL976H-MMAE enables stable and selective dual targeting of PD-L1 and AXLCancer Research · 2026
7. Development of Bispecific Antibody Targeting Human IL-17A and IL-6Antibodies · 2026
8. Preclinical evaluation of CPL423: a novel potent small-molecule inhibitor of TAM family and FLT3 kinase for cancer therapySHILAP Revista de lepidopterología · 2026
9. Identification of Pyrrolo[2,3-d]pyrimidine-Based Dual MERTK and FLT3 Inhibitor: Hit-to-Lead, Machine Learning, Modeling, Synthesis, and Biological EvaluationEuropean Journal of Pharmaceutical Sciences · 2026
10. Engineered fibroblast growth factor 1 variants uncouple glucose-lowering effects from mitogenic activity with therapeutic potential for type 2 diabetesMolecular Biomedicine · 2026
11. Rational deployment of molecular markers for the benzenediol lactones and related compounds biosynthesis in filamentous fungiPeerJ · 2025
12. Development of Prediction Capabilities for High-Throughput Screening of Physiochemical Properties by Biomimetic ChromatographyMolecules · 2025
13. From NMR to AI: Fusing ¹H and ¹³C Representations for Enhanced QSPR ModelingJournal of Chemical Information and Modeling · 2025
14. Factors Influencing the Dispersibility of Glycopyrronium Bromide and Indacaterol Maleate – Combined In Vitro and In Silico StudyAAPS PharmSciTech · 2025
15. Mapping protein-metabolite interactions in E. coli by integrating chromatographic techniques and co-fractionation mass spectrometryiScience · 2025
16. First-in-human study of CPL’116 – a dual JAK/ROCK inhibitor – in healthy subjectsFrontiers in Pharmacology · 2025
17. From NMR to AI: Do We Need ¹H NMR Experimental Spectra to Obtain High-Quality logD Prediction Models?Journal of Chemical Information and Modeling · 2025
18. Formulation development and scale-up of dutasteride liquisolid tabletsDrug Development and Industrial Pharmacy · 2025
19. The HECT ubiquitin‐protein ligases UPL1 and UPL2 are involved in degradation of Arabidopsis thaliana ACC synthase 7Physiologia Plantarum · 2025
20. Simultaneous 5-HT1BR agonist/5-HT6R antagonist action as a potential treatment of Parkinson’s disease and its comorbiditiesJournal of Pharmacology and Experimental Therapeutics · 2024